Mary E. Wright - 27 Feb 2026 Form 4 Insider Report for Inogen Inc (INGN)

Role: VP, Chief Accounting Officer
Signature: /s/ Mary Wright
Issuer symbol: INGN
Transactions as of: 27 Feb 2026
Net transactions value: -$11,639
Form type: 4
Filing time: 03 Mar 2026, 17:00:25 UTC
Previous filing: 07 Aug 2025
SEC: View on sec.gov

Quoteable Key Fact

"Mary E. Wright filed Form 4 for Inogen Inc (INGN) on 03 Mar 2026."

Quick Takeaways

This page summarizes Mary E. Wright's Form 4 filing for Inogen Inc (INGN).
13 reported transactions and 4 derivative rows are listed below.
Filing timestamp: 03 Mar 2026, 17:00.

What Changed

Previous filing in this sequence was filed on 07 Aug 2025.
Current net transaction value: -$11,639.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0002079955 Primary reporting owner

Wright Mary E

Relationship: VP, Chief Accounting Officer
Address: C/O INOGEN, INC., 500 CUMMINGS CENTER, SUITE 2800, BEVERLY
Signature: /s/ Mary Wright
Signature date: 03 Mar 2026

Transactions Table

INGN transaction

Common Stock

Award

Transaction value: $9,150
Shares: +1,500
Change %: +12%
Price: $6.10
Shares after: 13,680
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F1

INGN transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,755
Change %: +13%
Price: $0.000000
Shares after: 15,435
Date: 01 Mar 2026
Ownership: Direct

INGN transaction

Common Stock

Tax liability

Transaction value: $4,118
Shares: -675
Change %: -4.4%
Price: $6.10
Shares after: 14,760
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F2

INGN transaction

Common Stock

Award

Transaction value: $0
Shares: +1,351
Change %: +9.2%
Price: $0.000000
Shares after: 16,111
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F3

INGN transaction

Common Stock

Tax liability

Transaction value: $3,172
Shares: -520
Change %: -3.2%
Price: $6.10
Shares after: 15,591
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F4

INGN transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +2,750
Change %: +18%
Price: $0.000000
Shares after: 18,341
Date: 01 Mar 2026
Ownership: Direct

INGN transaction

Common Stock

Tax liability

Transaction value: $6,454
Shares: -1,058
Change %: -5.8%
Price: $6.10
Shares after: 17,283
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F2

INGN transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +3,001
Change %: +17%
Price: $0.000000
Shares after: 20,284
Date: 01 Mar 2026
Ownership: Direct

INGN transaction

Common Stock

Tax liability

Transaction value: $7,046
Shares: -1,155
Change %: -5.7%
Price: $6.10
Shares after: 19,129
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

INGN transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +8,000
Change %
Price: $0.000000
Shares after: 8,000
Date: 27 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,000
Exercise price
Footnotes: F5, F6

INGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -1,755
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,755
Exercise price
Footnotes: F5, F7

INGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -2,750
Change %: -50%
Price: $0.000000
Shares after: 2,749
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,750
Exercise price
Footnotes: F5, F8

INGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -3,001
Change %: -33%
Price: $0.000000
Shares after: 6,002
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,001
Exercise price
Footnotes: F5, F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
F2	The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026.
F3	The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on February 28, 2023.
F4	The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on February 28, 2023 and vested on March 1, 2026.
F5	Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F6	Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.
F7	The restriced stock units were fully vested on March 1, 2026.
F8	1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date.
F9	1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.